Intima-media thickening in patients with familial Mediterranean fever.

OBJECTIVE The aim of this study was to assess the frequency of atherosclerotic plaques and intima-media thickness (IMT) in patients with FMF and suitable controls. METHODS We studied 100 (46 males, 54 females; mean age: 40 +/- 6 years) patients with FMF. Also 94 (15 males, 79 females; mean age: 41 +/- 7 years) patients with SLE and 103 (44 males, 59 females; mean age: 40 +/- 5 years) apparently healthy volunteers were included as the control groups. Subclinical atherosclerosis was assessed by investigating atherosclerotic plaques and measuring IMT from carotid and common femoral arteries using B-mode ultrasonography (USG). Traditional atherosclerotic risk factors were also assessed. RESULTS Both FMF and SLE patients had significantly higher carotid (C-IMT) and femoral artery IMT (F-IMT) compared with healthy controls. This was also true after adjustment for atherosclerotic risk factors. Only patients with SLE were found to have higher frequency of atherosclerotic plaques in the carotid and in the carotid and/or femoral artery. When all atherosclerotic risk factors were adjusted, again only patients with SLE were found to have risk for atherosclerotic plaques. In FMF, whereas the presence of atherosclerotic plaques was only associated significantly with diabetes mellitus; C-IMT was correlated with age, BMI and fasting glucose; and F-IMT with age and BMI. CONCLUSIONS Increased atherosclerosis defined as the presence of plaques was not observed in patients with FMF. The significance of increased C- and F-IMT among patients with FMF must be further assessed.

[1]  E. Svenungsson,et al.  Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE‐related cardiovascular disease , 2009, Scandinavian journal of rheumatology.

[2]  M. González-Gay,et al.  Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain , 2008, Lupus.

[3]  T. Pincus,et al.  Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. , 2008, Arthritis and rheumatism.

[4]  B. Oran,et al.  The evaluation of carotid intima-media thickness in children with familial Mediterranean fever , 2008, Clinical Rheumatology.

[5]  A. Bakkaloğlu,et al.  Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis , 2008, Rheumatology International.

[6]  D. Isenberg,et al.  Systemic lupus erythematosus. , 2008, The New England journal of medicine.

[7]  M. Lidar,et al.  Familial Mediterranean fever: clinical, molecular and management advancements. , 2007, The Netherlands journal of medicine.

[8]  M. Vitale,et al.  Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. , 2007, Rheumatology.

[9]  S. Akar,et al.  Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever , 2007, Clinical Rheumatology.

[10]  A. Oto,et al.  Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. , 2006, Journal of the American College of Cardiology.

[11]  D. Booth,et al.  Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. , 2006, Rheumatology.

[12]  C. Franceschi,et al.  Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population , 2006, Journal of leukocyte biology.

[13]  I. Bruce.  'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. , 2005, Rheumatology.

[14]  E. Mannarino,et al.  Precocious intima-media thickening in patients with primary Sjögren's syndrome. , 2005, Arthritis and rheumatism.

[15]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[16]  H. Oflaz,et al.  Impaired endothelium‐dependent flow‐mediated dilation in Behçet's disease: more prominent endothelial dysfunction in patients with vascular involvement , 2005, International journal of clinical practice.

[17]  A. Bakkaloğlu,et al.  Familial Mediterranean Fever (FMF) in Turkey: Results of a Nationwide Multicenter Study , 2005, Medicine.

[18]  S. Bağcı,et al.  Does immune activation continue during an attack‐free period in familial Mediterranean fever? , 2004, Clinical and experimental immunology.

[19]  A. Bakkaloğlu,et al.  Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? , 2003, The Journal of rheumatology.

[20]  D. O'leary,et al.  Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. , 2003, Arthritis and rheumatism.

[21]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[22]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2015 .

[23]  G. Kitas,et al.  Accelerated atherogenesis in autoimmune rheumatic diseases. , 2002, Autoimmunity reviews.

[24]  A. Hughes,et al.  Is Carotid Artery Intima-Media Thickening a Reliable Marker of Early Atherosclerosis? , 2002, Journal of cardiovascular risk.

[25]  G. McColl,et al.  Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? , 2002, Arthritis and rheumatism.

[26]  H. Yazici,et al.  Acute phase response in familial Mediterranean fever , 2002, Annals of the rheumatic diseases.

[27]  G L Freeman,et al.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. , 2001, Arthritis and rheumatism.

[28]  A. Hofman,et al.  Is Carotid Intima-Media Thickness Useful in Cardiovascular Disease Risk Assessment?: The Rotterdam Study , 2001, Stroke.

[29]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[30]  Y. Shoenfeld,et al.  Autoimmunity in atherosclerosis , 2000, Clinical reviews in allergy & immunology.

[31]  M. Pepys,et al.  Acute phase response and evolution of familial Mediter ranean fever , 1999, The Lancet.

[32]  G D Lowe,et al.  Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. , 1999, Stroke.

[33]  J. Levy,et al.  Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program , 1998, Diabetes Care.

[34]  R. D'Agostino,et al.  Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.

[35]  A. Nicolaides,et al.  Ultrasound morphology classification of the arterial wall and cardiovascular events in a 6-year follow-up study. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[36]  A. Keech,et al.  Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. , 1995, Circulation.

[37]  M. Petri,et al.  Risk factors for coronary artery disease in patients with systemic lupus erythematosus. , 1992, The American journal of medicine.

[38]  J. Wójcicki,et al.  The effect of colchicine on the development of experimental atherosclerosis in rabbits. , 1986, Polish journal of pharmacology and pharmacy.

[39]  P. Lowe,et al.  The effects of colchicine on secretion into bile of bile salts, phospholipids, cholesterol and plasma membrane enzymes: bile salts are secreted unaccompanied by phospholipids and cholesterol. , 1984, The Biochemical journal.

[40]  A. Gangl,et al.  Effects of colchicine on the intestinal transport of endogenous lipid. Ultrastructural, biochemical, and radiochemical studies in fasting rats. , 1983, Gastroenterology.

[41]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[42]  F. Ottery,et al.  Colchicine inhibits hepatic cholesterol synthesis and microsomal 3‐hydroxy‐3‐methylglutaryl coenzyme A (HMG CoA reductase) activity , 1976, FEBS letters.

[43]  O. Stein,et al.  COLCHICINE-INDUCED INHIBITION OF LIPOPROTEIN AND PROTEIN SECRETION INTO THE SERUM AND LACK OF INTERFERENCE WITH SECRETION OF BILIARY PHOSPHOLIPIDS AND CHOLESTEROL BY RAT LIVER IN VIVO , 1974, The Journal of cell biology.

[44]  W. Faloon,et al.  Cholesterol lowering, fecal bile acid, and sterol changes during neomycin and colchicine. , 1970, The American journal of clinical nutrition.

[45]  Stein Harald Johnsen,et al.  Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease , 2009, Current cardiology reports.

[46]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[47]  E. Bonfá,et al.  Systemic lupus erythematosus and "lupus dyslipoproteinemia". , 2008, Autoimmunity reviews.

[48]  C. Sandborg,et al.  Management of dyslipidemia in children and adolescents with systemic lupus erythematosus. , 2007, Lupus.

[49]  H. Yazici,et al.  Atherosclerosis in Behçet's syndrome. , 2007, Clinical and experimental rheumatology.

[50]  M. Pras,et al.  Prevalence of ischemic heart disease in patients with familial Mediterranean fever. , 2001, The Israel Medical Association journal : IMAJ.

[51]  L. Kuller,et al.  Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[52]  M. Pepys,et al.  Acute phase response and evolution of familial Mediterranean fever. , 1999, Lancet.

[53]  A. Kubo,et al.  Relationship between autoantibodies and clinical parameters in Sjögren's syndrome. , 1993, Scandinavian journal of rheumatology.

[54]  A. Robert,et al.  Effect of colchicine on atherosclerosis. I. Clinical and biological studies. , 1985, Clinical physiology and biochemistry.